Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles

Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles

Item
http://www.wikidata.org/entity/Q34130228
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteersMucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriersA novel retinoic acid, catechin hydrate and mustard oil-based emulsion for enhanced cytokine and antibody responses against multiple strains of HIV-1 following mucosal and systemic vaccinations.Mucosal vaccination against serogroup B meningococci: induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants of Escherichia coli heat-labile enterotoxin.Evaluation of the LTK63 adjuvant effect on cellular immune responses to measles virus nucleoprotein.Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria.Intranasal vaccines for protection against respiratory and systemic bacterial infections.Improving vaccines by incorporating immunological coadjuvants.Nanoparticles and microparticles as vaccine-delivery systems.Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytesMucosal vaccination against bacterial respiratory infections.Concomitant administration of Mycobacterium bovis BCG with the meningococcal C conjugate vaccine to neonatal mice enhances antibody response and protective efficacy.Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform.
P2860

Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles

Item
http://www.wikidata.org/entity/Q34130228
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Enhancement of protective effi ...... t delivered with nanoparticles
@ast
Enhancement of protective effi ...... t delivered with nanoparticles
@en
Enhancement of protective effi ...... t delivered with nanoparticles
@nl
type
label
Enhancement of protective effi ...... t delivered with nanoparticles
@ast
Enhancement of protective effi ...... t delivered with nanoparticles
@en
Enhancement of protective effi ...... t delivered with nanoparticles
@nl
prefLabel
Enhancement of protective effi ...... t delivered with nanoparticles
@ast
Enhancement of protective effi ...... t delivered with nanoparticles
@en
Enhancement of protective effi ...... t delivered with nanoparticles
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Enhancement of protective effi ...... t delivered with nanoparticles
@en
P2093
P2860
P304
P31
P356
10.1128/IAI.70.9.4785-4790.2002
P407
P433
P478
P50
P577
P698
P921
P932